Oncept Il-2

Oncept Il-2

Marketed minn: Merial 
Ingredjent attiv: vCP1338 virus

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Onsior

Onsior

Marketed minn: Elanco GmbH
Ingredjent attiv: robenacoxib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Osurnia

Osurnia

Marketed minn: Elanco GmbH
Ingredjent attiv: terbinafine / florfenicol, betamethasone acetate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Oxyglobin

Oxyglobin

Marketed minn: OPK Biotech Netherlands BV
Ingredjent attiv: emoglobina glutamer-200 (bovini)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Obizur

Obizur

Marketed minn: Baxalta Innovations GmbH
Ingredjent attiv: susoctocog alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Otezla

Otezla

Marketed minn: Celgene Europe BV
Ingredjent attiv: apremilast

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olanzapine Mylan

Olanzapine Mylan

Marketed minn: Mylan S.A.S.
Ingredjent attiv: olanzapine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Odefsey

Odefsey

Marketed minn: Gilead Sciences Ireland UC
Ingredjent attiv: emtricitabine, rilpivirina hydrochloride, tenofovir alafenamide

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Onivyde

Onivyde

Marketed minn: Les Laboratoires Servier
Ingredjent attiv: irinotecan hydrochloride trihydrate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olanzapine Glenmark

Olanzapine Glenmark

Marketed minn: Glenmark Pharmaceuticals Europe Limited
Ingredjent attiv: olanzapine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ofev

Ofev

Marketed minn: Boehringer Ingelheim International GmbH
Ingredjent attiv: nintedanib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Orencia

Orencia

Marketed minn: Bristol-Myers Squibb Pharma EEIG
Ingredjent attiv: Abatacept

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ovitrelle

Ovitrelle

Marketed minn: Merck Europe B.V.
Ingredjent attiv: choriogonadotropin alfa

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ocaliva

Ocaliva

Marketed minn: Intercept Pharma International Ltd
Ingredjent attiv: Obeticholic acid

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olanzapine Teva

Olanzapine Teva

Marketed minn: Teva Pharma
Ingredjent attiv: olanzapine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Odomzo

Odomzo

Marketed minn: Sun Pharmaceutical Industries Europe B.V.
Ingredjent attiv: sonidegib difosfat

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Orkambi

Orkambi

Marketed minn: Vertex Pharmaceuticals (Ireland) Limited
Ingredjent attiv: Lumacaftor, ivacaftor

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Ongentys

Ongentys

Marketed minn: Bial - Portela Cª, S.A.
Ingredjent attiv: opicapone

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Oslif Breezhaler

Oslif Breezhaler

Marketed minn: Novartis Europharm Limited 
Ingredjent attiv: indacaterol maleate

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Opdivo

Opdivo

Marketed minn: Bristol-Myers Squibb Pharma EEIG
Ingredjent attiv: nivolumab

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olysio

Olysio

Marketed minn: Janssen-Cilag International N.V.
Ingredjent attiv: simeprevir

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olanzapine Apotex

Olanzapine Apotex

Marketed minn: Apotex Europe B.V. 
Ingredjent attiv: olanzapine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Orgalutran

Orgalutran

Marketed minn: Merck Sharp and Dohme B.V
Ingredjent attiv: ganirelix

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Optaflu

Optaflu

Marketed minn: Seqirus GmbH
Ingredjent attiv: virus tal-influwenza antiġeni tal-wiċċ (haemagglutinin u neuraminidase), inattivati, tar-razez li ġejjin:/California/7/2009 (H1N1)pdm09 - like strain(A/Brisbane/10/2010, tat-tip selvaġġ)A/Svizzera/9715293/2013 (H3N2) like strain(A/Nofsinhar l-Awstralja/55/2014, tat-tip selvaġġ)B/kulħadd jinstemgħu/3073/2013–like strain(B/Utah/9/2014, tat-tip selvaġġ)

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olumiant

Olumiant

Marketed minn: Eli Lilly Nederland B.V.
Ingredjent attiv: baricitinib

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Orfadin

Orfadin

Marketed minn: Swedish Orphan Biovitrum International AB
Ingredjent attiv: nitisinone

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Opsumit

Opsumit

Marketed minn: Janssen-Cilag International N V  
Ingredjent attiv: Macitentan

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olanzapine Cipla (previously Olanzapine Neopharma)

Olanzapine Cipla (previously Olanzapine Neopharma)

Marketed minn: Cipla (EU) Limited
Ingredjent attiv: olanzapine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olanzapine Glenmark Europe

Olanzapine Glenmark Europe

Marketed minn: Glenmark Pharmaceuticals Europe Limited 
Ingredjent attiv: olanzapine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency

Olazax

Olazax

Marketed minn: Glenmark Pharmaceuticals s.r.o. 
Ingredjent attiv: olanzapine

Disponibbli fi: Unjoni Ewropea
Lingwa: Malti
Sors: EMA - European Medicines Agency